Abstract

A Prospective, Single Arm, Open Phase II Clinical Trial of Adjuvant Treatment of Stage III Gastric Cancer (PD-L1 + / MSI-H / EB +) With Anti-PD-1 Antibody and First-line Chemotherapy

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.